Discover the differences
Providing more than just results
Therapeutics testing covers a wide-range of areas from controlled substance monitoring to pharmacogenomics (PGx). We provide access to Mayo Clinic experts and a test menu developed through evidence-driven clinical innovation to help clinicians guide patient care.
Discover how the smallest differences can have the greatest impact. Let's find the right answers together.
By the numbers
We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.
190+
laboratory tests developed for our specialized therapeutics test menu
50+
years of research in pharmacogenomics
25M
tests performed
annually
24/7
support from Mayo Clinic physicians and scientists
An individualized approach
When PGx is incorporated into clinical practice, drug selection is enhanced with the genetic profile of individual patients, improving the clinician’s ability to avoid adverse drug reactions and maximize therapeutic efficacy.
Differences that matter
We understand that interpreting testing results can be tricky, so we provide health care providers with customized clinical guidance based on testing results.
Access to Mayo Clinic expertise
When you partner with Mayo Clinic Laboratories, you extend your network to include some of the world’s leading genetic experts. Mayo Clinic clinicians, laboratorians, and genetic counselors are available to discuss testing options, interpret results, or help with case review and coordination.
The Latest
Visit Mayo Clinic Laboratories at booth #2047 to learn about our comprehensive therapeutics test offerings. Developed by board-certified experts in clinical chemistry, molecular, and toxicology testing, our testing is designed to detect and monitor therapeutic and illicit drugs across several relevant specimen types.
Join us for the APA Annual Meeting 2023, the premier event for psychiatrists and mental health professionals. This year's meeting will be held May 20–24 in San Francisco and will feature an exciting program of educational sessions, expert speakers, and networking opportunities.
Misdiagnosed with acromegaly, a disease marked by too much growth hormone, and plagued by a host of mysterious health problems from unnecessary medications, Kelly DuBois finally found answers after pharmacogenomic testing from Mayo Clinic Laboratories put her on a path toward healing.
Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories’ new marijuana monitoring evaluation, which identifies metabolites of both delta-9 tetrahydrocannabinol (THC) and delta-8 THC to accurately identify and characterize patients’ marijuana use.
For Billy Dowell Jr., a competitive golfer, focus, determination, and course correction are essential to excelling at the sport. These skills, along with routine follow-up care and testing, are also important to navigating a life impacted by multiple chronic autoimmune conditions.